Company research
LUDWIG ENTERPRISES, INC.
CIK 1960262Updated Sep 27, 2026
SecurityLUDG · OTC · equity
LUDG price & chart
Loading TradingView…
OTC:LUDG on TradingView ↗About the company
We are an early-stage genomics-based company focused on developing testing approaches for the assessment of inflammation-related chronic diseases, including cancers. We believe we are the first to employ a non-invasive cheek swab test to collect mRNA samples in quantities sufficient for our intended analyses. Our approach seeks to enable the identification of upstream inflammation-driven biomarkers to support personalized treatment decisions.
In the news
No coverage from other publishers is available.
SEC disclosures
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 247,527Source | 197,556Source | 112,468Source | 516,195Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 9,166Source | — | — | — |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 0Source | — | — | — |
| Inventory, NetUSD | 4,529Source | 3,048Source | — | — |
| Assets, CurrentUSD | 238,361Source | 197,556Source | 112,468Source | 516,195Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 4,635,733Source | 2,575,701Source | 1,574,033Source | 1,342,362Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 7,000Source | 7,000Source | 7,000Source | 7,000Source |
| Common Stock, Value, IssuedUSD | 162,568Source | 160,511Source | 155,463Source | 315,188Source |
| Additional Paid in CapitalUSD | 4,938,025Source | 4,713,710Source | 2,618,454Source | 637,577Source |
| Retained Earnings (Accumulated Deficit)USD | -9,495,799Source | -7,259,366Source | -4,242,482Source | -1,785,932Source |
| Stockholders' Equity Attributable to ParentUSD | -4,388,206Source | -2,378,145Source | -1,461,565Source | -826,167Source |
| Liabilities and EquityUSD | 247,527Source | 197,556Source | 112,468Source | 516,195Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 4,635,733Source | 2,575,701Source | 1,574,033Source | 1,342,362Source |
| Additional Financial Items | ||||
| Long-term DebtUSD | — | — | 100,000Source | 1,232,857Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | -2,456,550Source | -965,150Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in InventoriesUSD | 1,481Source | 3,048Source | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -644,842Source | -660,302Source | -647,860Source | -444,805Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -9,166Source | — | — | — |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 647,267Source | 558,708Source | 240,000Source | 836,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | -407,860Source | 391,195Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | 6,741Source | 108,335Source | 516,195Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 12,768Source | 5,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Debt Issuance CostsUSD | — | 15,000Source | — | — |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | 15,000Source | — | — |
| Gain (Loss) on Disposition of BusinessUSD | — | 203,319Source | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | -117,217Source | — | — | 44,475Source |
| General and Administrative ExpenseUSD | — | 1,132,785Source | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | -2,236,433Source | -3,051,687Source | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | 34,803Source | — | — |
| InterestExpenseNonoperatingUSD | 91,922Source | — | — | — |
| Inventory Write-downUSD | — | 0Source | — | — |
| Investment Income, InterestUSD | 6,000Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | -2,236,433Source | -3,016,884Source | -2,456,550Source | -965,150Source |
| Noncash Merger Related CostsUSD | — | 100,800Source | — | — |
| Nonoperating Income (Expense)USD | -461,753Source | -1,753,498Source | — | — |
| Operating ExpensesUSD | 1,774,680Source | 1,298,406Source | — | — |
| Other Nonoperating Income (Expense)USD | — | — | -1,002,682Source | -404,645Source |
| Proceeds from Issuance of Redeemable Preferred StockUSD | — | — | — | 6,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | — | 217Source | — | — |
| Operating Income (Loss)USD | -1,774,680Source | -1,298,189Source | 1,453,868Source | 560,505Source |
| Other Nonoperating Income (Expense)USD | — | — | -1,002,682Source | -404,645Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -2,236,433Source | -3,051,687Source | -2,456,550Source | -965,150Source |
| Net Income (Loss) Attributable to ParentUSD | -2,236,433Source | -3,016,884Source | -2,456,550Source | -965,150Source |
| Earnings Per Share, BasicUSD per share | -0.01Source | -0.02Source | — | — |
| Earnings Per Share, DilutedUSD per share | -0.01Source | -0.02Source | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 161,824,928Source | — | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 161,824,928Source | 158,606,794Source | — | — |
| Interest Expense (non-operating)USD | 91,922Source | — | — | — |
| Additional Financial Items | ||||
| General and Administrative ExpenseUSD | — | 1,132,785Source | — | — |
| Income (Loss) Attributable to Parent, before TaxUSD | — | — | -1,453,868Source | -560,505Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | -2,236,433Source | -3,051,687Source | — | — |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | -0.01Source | -0.02Source | — | — |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | -0.01Source | -0.02Source | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | 34,803Source | — | — |
| Interest ExpenseUSD | — | — | 15,714Source | 14,068Source |
| Interest Expense, DebtUSD | 91,922Source | 56,794Source | — | — |
| Investment Income, InterestUSD | 6,000Source | — | — | — |
| Labor and Related ExpenseUSD | — | 1,004,574Source | — | — |
| Marketing and Advertising ExpenseUSD | 255,160Source | 216,318Source | — | — |
| Nonoperating Income (Expense)USD | -461,753Source | -1,753,498Source | — | — |
| Operating ExpensesUSD | 1,774,680Source | 1,298,406Source | — | — |
| Other General ExpenseUSD | — | — | 1,017,470Source | 447,260Source |
| Research and Development ExpenseUSD | 231,593Source | 165,621Source | 436,398Source | 113,245Source |